ReviewFrontiers in immunology2024

Treatment of rosacea with upadacitinib and abrocitinib: case report and review of evidence for Janus kinase inhibition in rosacea.

Ting Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.